Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
40 studies found for:    Porphyria
Show Display Options
Rank Status Study
1 Completed Observational Study of Acute Intermittent Porphyria Patients
Condition: Acute Intermittent Porphyria
Intervention:
2 Active, not recruiting EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Condition: Acute Hepatic Porphyria
Intervention:
3 Not yet recruiting Dental Health, Diet, Inflammation and Biomarkers in Patients With Acute Intermittent Porphyria(AIP)
Condition: Acute Intermittent Porphyria
Intervention:
4 Recruiting Longitudinal Study of the Porphyrias
Conditions: Acute Porphyrias;   Cutaneous Porphyrias
Intervention:
5 Enrolling by invitation Acute Porphyria Biomarkers
Conditions: Acute Intermittent Porphyria;   Hereditary Coproporphyria;   Variegate Porphyria
Intervention: Drug: Hemin
6 Recruiting Panhematin for Prevention of Acute Attacks of Porphyria Panhematin for Prevention of Acute Attacks of Porphyria
Conditions: Acute Intermittent Porphyria;   Hereditary Coproporphyria;   Variegate Porphyria
Interventions: Biological: Hemin for injection;   Other: Placebo
7 Recruiting Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria
Condition: Acute Porphyrias
Interventions: Biological: Panhematin;   Other: Placebo
8 Recruiting Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Interventions: Drug: Hydroxychloroquine;   Procedure: Phlebotomy
9 Recruiting Clinical Diagnosis of Acute Porphyria
Conditions: Hereditary Coproporphyria (HCP);   Acute Intermittent Porphyria (AIP);   Variegate Porphyria (VP)
Intervention:
10 Completed Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria
Condition: Acute Intermittent Porphyria
Interventions: Genetic: rAAV2/5-PBGD vector dosage 1;   Genetic: rAAV2/5-PBGD vector dosage 2;   Genetic: rAAV2/5-PBGD vector dosage 3;   Genetic: rAAV2/5-PBGD vector dosage 4
11 Completed
Has Results
Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
Condition: Porphyria Cutanea Tarda
Intervention: Drug: Deferasirox
12 Enrolling by invitation A Study to Evaluate Long-term Safety and Clinical Activity of ALN-AS1 in Patient With Acute Intermittent Porphyria (AIP)
Condition: Acute Intermittent Porphyria
Intervention: Drug: ALN-AS1
13 Completed Risk Factors of Porphyria Cutanea Tarda (PCT)
Condition: Porphyria Cutanea Tarda
Intervention:
14 Recruiting A Phase 1 Study of ALN-AS1 in Patients With Acute Intermittent Porphyria (AIP)
Condition: Acute Intermittent Porphyria
Interventions: Drug: ALN-AS1;   Drug: Sterile Normal Saline (0.9% NaCl)
15 Completed Study of Nutritional Factors in Porphyria
Condition: Porphyria
Intervention:
16 Unknown  Studies in Porphyria I: Characterization of Enzyme Defects
Condition: Porphyria
Intervention:
17 Completed Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria
Condition: Porphyria
Interventions: Drug: heme arginate;   Drug: tin mesoporphyrin
18 Completed Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
Condition: Porphyria
Intervention: Drug: luteinizing hormone-releasing factor
19 Completed Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
Condition: Porphyria
Interventions: Drug: heme arginate;   Drug: tin mesoporphyrin
20 Completed Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
Condition: Porphyria
Interventions: Drug: heme arginate;   Drug: tin mesoporphyrin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.